Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Flow Cytometric Analysis of Brain Tumor Stem Cells.
Subapanditha MK, Adile AA, Venugopal C, Singh SK. Subapanditha MK, et al. Methods Mol Biol. 2019;1869:69-77. doi: 10.1007/978-1-4939-8805-1_6. Methods Mol Biol. 2019. PMID: 30324514
BMI1 is a therapeutic target in recurrent medulloblastoma.
Bakhshinyan D, Venugopal C, Adile AA, Garg N, Manoranjan B, Hallett R, Wang X, Mahendram S, Vora P, Vijayakumar T, Subapanditha M, Singh M, Kameda-Smith MM, Qazi M, McFarlane N, Mann A, Ajani OA, Yarascavitch B, Ramaswamy V, Farooq H, Morrissy S, Cao L, Sydorenko N, Baiazitov R, Du W, Sheedy J, Weetall M, Moon YC, Lee CS, Kwiecien JM, Delaney KH, Doble B, Cho YJ, Mitra S, Kaplan D, Taylor MD, Davis TW, Singh SK. Bakhshinyan D, et al. Oncogene. 2019 Mar;38(10):1702-1716. doi: 10.1038/s41388-018-0549-9. Epub 2018 Oct 22. Oncogene. 2019. PMID: 30348991
Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma.
Qazi MA, Salim SK, Brown KR, Mikolajewicz N, Savage N, Han H, Subapanditha MK, Bakhshinyan D, Nixon A, Vora P, Desmond K, Chokshi C, Singh M, Khoo A, Macklin A, Khan S, Tatari N, Winegarden N, Richards L, Pugh T, Bock N, Mansouri A, Venugopal C, Kislinger T, Goyal S, Moffat J, Singh SK. Qazi MA, et al. Among authors: subapanditha mk. Cell Rep. 2022 Sep 27;40(13):111420. doi: 10.1016/j.celrep.2022.111420. Cell Rep. 2022. PMID: 36170831 Free article.
An effective kinase inhibition strategy for metastatic recurrent childhood medulloblastoma.
Adile AA, Bakhshinyan D, Suk Y, Uehling D, Saini M, Aman A, Magolan J, Subapanditha MK, McKenna D, Chokshi C, Savage N, Kameda-Smith MM, Venugopal C, Singh SK. Adile AA, et al. Among authors: subapanditha mk. J Neurooncol. 2023 Jul;163(3):635-645. doi: 10.1007/s11060-023-04372-w. Epub 2023 Jun 24. J Neurooncol. 2023. PMID: 37354357
Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence.
Bakhshinyan D, Adile AA, Liu J, Gwynne WD, Suk Y, Custers S, Burns I, Singh M, McFarlane N, Subapanditha MK, Qazi MA, Vora P, Kameda-Smith MM, Savage N, Desmond KL, Tatari N, Tran D, Seyfrid M, Hope K, Bock NA, Venugopal C, Bader GD, Singh SK. Bakhshinyan D, et al. Among authors: subapanditha mk. Sci Adv. 2021 Dec 10;7(50):eabi5568. doi: 10.1126/sciadv.abi5568. Epub 2021 Dec 8. Sci Adv. 2021. PMID: 34878832 Free PMC article.
A novel stem cell culture model of recurrent glioblastoma.
Qazi MA, Vora P, Venugopal C, McFarlane N, Subapanditha MK, Murty NK, Hassell JA, Hallett RM, Singh SK. Qazi MA, et al. Among authors: subapanditha mk. J Neurooncol. 2016 Jan;126(1):57-67. doi: 10.1007/s11060-015-1951-6. J Neurooncol. 2016. PMID: 26498281
Differentiation of Brain Tumor Initiating Cells.
Kameda-Smith MM, Subapanditha MK, Salim SK, Venugopal C, Singh SK. Kameda-Smith MM, et al. Among authors: subapanditha mk. Methods Mol Biol. 2019;1869:85-91. doi: 10.1007/978-1-4939-8805-1_8. Methods Mol Biol. 2019. PMID: 30324516
Wnt activation as a therapeutic strategy in medulloblastoma.
Manoranjan B, Venugopal C, Bakhshinyan D, Adile AA, Richards L, Kameda-Smith MM, Whitley O, Dvorkin-Gheva A, Subapanditha M, Savage N, Tatari N, McKenna D, Bassey-Archibong B, Winegarden N, Hallett R, Provias JP, Yarascavitch B, Ajani O, Fleming A, Bader GD, Pugh TJ, Doble BW, Singh SK. Manoranjan B, et al. Nat Commun. 2020 Aug 28;11(1):4323. doi: 10.1038/s41467-020-17953-4. Nat Commun. 2020. PMID: 32859895 Free PMC article.
CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.
Seyfrid M, Maich WT, Shaikh VM, Tatari N, Upreti D, Piyasena D, Subapanditha M, Savage N, McKenna D, Mikolajewicz N, Han H, Chokshi C, Kuhlmann L, Khoo A, Salim SK, Archibong-Bassey B, Gwynne W, Brown K, Murtaza N, Bakhshinyan D, Vora P, Venugopal C, Moffat J, Kislinger T, Singh S. Seyfrid M, et al. J Immunother Cancer. 2022 Jan;10(1):e003289. doi: 10.1136/jitc-2021-003289. J Immunother Cancer. 2022. PMID: 35017149 Free PMC article.
20 results